News | Magnetic Resonance Imaging (MRI) | April 18, 2023

4D Flow MRI, 3D Phantoms Benefit Atrial Fibrillation Patients

Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting at the Hawaiian Convention Center suggest that correctly occluded left atrial appendages (LAAs) could present maximal reduction in left atrial (LA) flow stasis and thrombogenicity, offering a clinical goal for the procedure in patients with atrial fibrillation.

Production of three life-sized left atrial phantoms 


April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting at the Hawaiian Convention Center suggest that correctly occluded left atrial appendages (LAAs) could present maximal reduction in left atrial (LA) flow stasis and thrombogenicity, offering a clinical goal for the procedure in patients with atrial fibrillation. 

Pointing out the paucity of knowledge in atrial fibrillation (AF) populations regarding the actual flow dynamic changes before and after percutaneous left atrial appendage occlusion (LAAO), “we aimed to evaluate LA flow dynamics for pre-occluded, correctly occluded, and incorrectly occluded LAAs in patients with AF via four-dimensional (4D) flow MRI and 3D printed phantoms,” said Min Jae Cha from the department of radiology at Chung-Ang University Hospital in Seoul, South Korea. 
In this ARRS Annual Meeting Summa Cum Laude award-winning Online Poster, life-sized LA phantoms of an 86-year-old patient with persistent AF were 3D printed from cardiac CT images. Setting a custom-made, closed-loop flow circuit, a pump delivered pulsatile pulmonary venous flow. Using a 3-T scanner (Philips Achieva TX), 4D flow MRI was obtained, then analyzed via MATLAB-based software. Flow metrics associated with blood stasis and thrombogenicity—stasis volume defined by velocity threshold (|V| < 3 cm/s), time-averaged wall shear stress (WSS), and endothelial cell activation potential (ECAP)—were compared among three conditions. 

According to Cha et al., different spatial distributions, orientations, and magnitudes of flow were directly visualized within the three LA phantoms using 4D flow MRI. The time-averaged volume and percentage of LA flow stasis were consistently minimized in the correctly occluded model (70.82 ml, 38.97%), followed by the incorrectly occluded (73.17 ml, 39.02%) and pre-procedural (79.11 ml, 39.71%) models. 

Additionally, the pre-occluded model was associated with the lowest surface-and-time-averaged WSS (0.048 Pa), followed by incorrectly (0.059 Pa) and correctly (0.072 Pa) occluded models. Conversely, ECAP was lowest in the correctly occluded model (4.004 Pa-1), followed by the incorrectly- (4.792 Pa-1) and pre-occluded (5.861 Pa-1) models. 

For more information: www.arrs.org 
Find more ARRS23 Annual Meeting coverage here 


Related Content

News | Left Atrial Appendage (LAA) Occluders

April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum ...

Home April 04, 2024
Home
News | Left Atrial Appendage (LAA) Occluders

March 18, 2024 — Conformal Medical, Inc. announced that the CLAAS System was featured in a podium presentation at the ...

Home March 18, 2024
Home
News | Left Atrial Appendage (LAA) Occluders

January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in ...

Home January 08, 2024
Home
News | Left Atrial Appendage (LAA) Occluders

October 25, 2023 — ConcertAI's TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for ...

Home October 25, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...

Home October 25, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

October 19, 2023 — Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early ...

Home October 19, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...

Home September 07, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...

Home July 26, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

Home May 25, 2023
Home
News | Left Atrial Appendage (LAA) Occluders

May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

Home May 22, 2023
Home
Subscribe Now